Opioid MDL Special Master Sets Data Production Guidelines
Law360 (January 28, 2020, 6:25 PM EST) -- A special master in the opioid multidistrict litigation in Ohio on Monday outlined what data pharmacies have to turn over to local governments in the litigation, including information on non-opioids that are associated with "doctor-shopping."
Special Master David Cohen said that the pharmacies have to produce data for 14 benzodiazepines and four muscle relaxers, along with the prescription data for opioids. According to the Ohio Board of Pharmacy, the most glaring "red flag" combinations involve mixing opioids with a benzodiazepine and a muscle relaxer, Cohen said.
The pharmacies had previously agreed to release data for a sedative called alprazolam and for...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!